Biomaterials pp 285-305 | Cite as

Hyaluronic acid

  • David A. Swann
  • Jing-wen Kuo


This review will focus in a selective way on the structure and function of hyaluronic acid (HA)*, and the development of HA-containing products, and, we hope, shed some light on the factors that have influenced the development of these biomaterials.


Hyaluronic Acid Synovial Fluid Sodium Hyaluronate Intraarticular Injection Synovial Fluid11 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Meyer, K. & Palmer, J. (1934) The polysaccharide of the vitreous humour. J. Biol. Chem. 107: 629–634.Google Scholar
  2. 2.
    Everd, D. & Whelan, J. (eds) (1989) The Biology of Hyaluronan, Ciba Foundation Symposium, Vol. 143. Wiley, Chichester, UK.Google Scholar
  3. 3.
    Laurent, T.C. (1987) Biochemistry of hyaluronan. Acta Otolaryngol. (Stockh.) suppl. 442: 7–24.CrossRefGoogle Scholar
  4. 4.
    Swann, D.A. (1980) Chemistry and biology of the vitreous body. Int. Rev. Exp. Pathol. 2: 1–57.Google Scholar
  5. 5.
    Comper, W.D. & Laurent, T.C. (1978) Physiological function of connective tissue polysaccharides. Physiol. Rev. 58: 255–315.Google Scholar
  6. 6.
    Meyer, K. (1958) Chemical structure of hyaluronic acid. Fed. Proc. 17: 1075–1077.Google Scholar
  7. 7.
    Flowers, H.M. & Jeanloz, R.W. (1964) The synthesis of the repeating unit of hyaluronic acid. Biochemistry 3: 123–125.CrossRefGoogle Scholar
  8. 8.
    Varma, R., Varma, R.S., Allen, W. & Wardi A.H. (1978) Neutral sugars from the hyaluronate-peptide of vitreous humour. Carbohvdr. Res. 32: 386–395.CrossRefGoogle Scholar
  9. 9.
    Katzman, R.L. (1974) Absence of arabinase in bovine brain hyaluronic acid as analyzed by gas-liquid chromatography. Biochim. Biophys. Acta 372: 53.Google Scholar
  10. 10.
    Varga, L. (1955) Studies on hyaluronic acid prepared from the vitreous body. J. Biol. Chem. 217: 651–658.Google Scholar
  11. 11.
    Silpananta, P., Dunstone, J.R. & Ogston, A.G. (1968) Fractionation of a hyaluronic acid preparation in a density gardient. Some properties of the hyaluronic acid. Biochem. J. 109: 43–50.CrossRefGoogle Scholar
  12. 12.
    Welsh, E.J., Rees, D.A., Morris, E.R. & Madden, J.K. (1980) Competitive inhibition evidence for specific intermolecular interactions in hyaluronate solutions. J. Mol. Biol. 138: 375–382.CrossRefGoogle Scholar
  13. 13.
    Silver, F.H. & Swann, D.A. (1982) Laser light scattering measurements on vitreous and rooster comb hyaluronic acids. Int. J. Macromol. 4: 425–429.CrossRefGoogle Scholar
  14. 14.
    Turner, R.E., Lin, P.Y. & Cowman, M.K. (1988) Self-association of hyaluronate segments in acqueous NaCI solution. Arch. Biochem. Biophvs. 265: 484–495.CrossRefGoogle Scholar
  15. 15.
    Laurent, T.C., Ryan, M. & Pietruszkiewicz, A. (1960) Fractionation of hyaluronic acid: The polydispersity of hyaluronic acid from the bovine vitreous body. Biochem. Biophys. Acta 42: 476–485.CrossRefGoogle Scholar
  16. 16.
    Laurent, T.C. & Gergely, J. (1955) Light scattering studies on hyaluronic acid. J. Biol. Chem. 212: 325–333.Google Scholar
  17. 17.
    Laurent, U.B.G. & Granath, K.A. (1983) The molecular weight of hyaluronate in the aqueous humour and vitreous body of rabbit and cattle eyes. Expt. Eye Res. 36: 481–492.CrossRefGoogle Scholar
  18. 18.
    Swann, D.A., Silver, F.H., Sotman, S.L. & Hermann, H. (1982) Measurements of reducing end groups on bovine vitreous humor hyaluronic acid by reaction with 14[C] cyanide. Biochem. J. 207: 409–414.CrossRefGoogle Scholar
  19. 19.
    Swann, D.A. (1969) Studies on the structure of hyaluronic acid. Characterization of the product formed when hyaluronic acid is treated with ascorbic acid. Biochem. J. 114: 819–825.CrossRefGoogle Scholar
  20. 20.
    Ogston, A.G. & Stanier, J.E. (1951) The dimensions of the particle of hyaluronic acid complex in synovial fluid. Biochem. J. 49: 585–590.CrossRefGoogle Scholar
  21. 21.
    Ogston, A.G. & Stanier, J.E. (1953) Composition and properties of hyaluronic acid complex of ox synovial fluid. Discuss. Faraday Soc. 13: 275–280.CrossRefGoogle Scholar
  22. 22.
    Atkins, E.D.T., Meader, D. & Scott, J.E. (1980) Model for hyaluronic acid incorporating four intramolecular hydrogen bonds. Int. J. Biol. Macromol. 2: 318–319.CrossRefGoogle Scholar
  23. 23.
    Heatley, F. & Scott, J.E. (1988) A water molecule participates in the secondary structure of hyaluronan. Biochem. J. 254: 489–493.CrossRefGoogle Scholar
  24. 24.
    Scott, J.E., Cummings, C., Brass, A. & Chen, Y. (1991) Secondary and tertiary structures of hyaluronanin aqueous solution investigated by rotary shadowing-electron microscopy and computer simulation. Biochem. J. 274: 699–705.CrossRefGoogle Scholar
  25. 25.
    Swann, D.A. (1970) On the state of hyaluronic acid in a connective tissue matrix. In The Chemistry and Biology of the Intercellular Matrix (ed. Balazs, E.A.), Vol. II, p. 743. Academic, New York.Google Scholar
  26. 26.
    Atkins, E.D.T. & Sheehan, J.K. (1973) Hyaluronates: relation between molecular conformations. Science 179: 562–564.CrossRefGoogle Scholar
  27. 27.
    Sheehan, J., Atkins, E. & Nieduszynski, I. (1975) Studies on the connective tissue polysaccharides. Two-dimensional packing schemes for three-fold hyaluronate chains. J. Mol. Biol. 91: 153–163.CrossRefGoogle Scholar
  28. 28.
    Winter, W.T., Smith, P.J.C. & Arnott, S. (1975) Hyaluronic acid: structure of a fully extended 3-fold helical sodium salt and comparison with the less extended 4-fold helical forms. J. Mol. Biol. 99: 219–235.CrossRefGoogle Scholar
  29. 29.
    Winter, W.T. & Arnott, S. (1977) Hyaluronic acid: The role of divalent cations in conformation and packing. J. Mol. Biol. 177: 761–784.CrossRefGoogle Scholar
  30. 30.
    Sheehan, J.K., Gardner, K.H. & Atkins, E.D.T. (1977) Hyaluronic acid: A double helical structure in the presence of potassium at low pH and found also with the cations ammonium, rubidium and caesium. J. Mol. Biol. 117: 113–135.CrossRefGoogle Scholar
  31. 31.
    Arnott, S., Mitra, A.K. & Raghunathan, S. (1983) Hyaluronic acid double helix. J. Mol. Biol. 169: 861–872.CrossRefGoogle Scholar
  32. 32.
    Staskus, P.W. & Johnson, W.C. Jr (1988) Double-stranded structure for hyaluronic acid in ethanol-aqueous solution as revealed by circular dichroism of oligomers. Biochemistry 27: 1528–1534.CrossRefGoogle Scholar
  33. 33.
    Swann, D.A. (1968) Studies on hyaluronic acid. I. The preparation and properties of rooster comb hyaluronic acid. Biochim. Biophys. Acta 156: 17–30.CrossRefGoogle Scholar
  34. 34.
    Hardingham, T. & Muir, H. (1972) The specific interaction of hyaluronic acid with cartilage proteoglycans. Biochim. Biophys. Acta 279: 401–405.CrossRefGoogle Scholar
  35. 35.
    Tengblad, A. (1981) A comparative study of the binding of cartilage link protein and the hyaluronate-binding region of the cartilage proteoglycan to hyaluronate-substituted sepharose gel. Biochem. J. 199: 297–305.CrossRefGoogle Scholar
  36. 36.
    Silpanata, P., Dunstone, J.R. & Ogston, A.G. (1969) Protein associated with hyaluronic acid in ox synovial fluid. Austr. J. Biol. Sci. 22, 1031–1037.Google Scholar
  37. 37.
    Swann, D.A. (1978) Macromolecules of synovial fluid. In The Joints and Synovial Fluid (ed. Sokoloff.), Vol. 1, pp. 407–435. Academic, New York.Google Scholar
  38. 38.
    Swann, D.A., Slayter, H.S. & Silver, F.H. (1981) The molecular structure of lubricating glycoprotein-I, the boundary lubricant for articular cartilage. J. Biol. Chem. 256, 5921–5925.Google Scholar
  39. 39.
    Swann, D.A., Radin, E.L., Nazimiec, M., Weisser, P.A., Curran, N. & Lewinnek, G. (1974) Role of hyaluronic acid in joint lubrication. Ann. of Rheum. Dis. 33: 318–326.CrossRefGoogle Scholar
  40. 40.
    Delpech, B. & Halavent, C. (1981) Characterization and purification from human brain of a hyaluronic acid-binding glycoprotein, hyaluronectin. J. Neurochem. 36: 855–859.CrossRefGoogle Scholar
  41. 41.
    Yamada, K.M., Kennedy, D.W., Kimata, K. & Pratt, R.M. (1980) Characterization of fibronectin interactions with glycosaminoglycans and identification of active proteolytic fragments. J. Biol. Chem. 255: 6055–6063.Google Scholar
  42. 42.
    Isemura, M., Yosizawa, Z., Koide, T. & Ono, T. (1982) Interaction of fibronectin and its proteolytic fragments with hyaluronic acid. J. Biochem. (Tokyo) 91: 731–4.Google Scholar
  43. 43.
    D’Souza, M. & Datta, K. (1986) A novel glycoprotein that binds to hyaluronic acid. Biochem. Int. 13: 79–88.Google Scholar
  44. 44.
    Laurent, T.C. & Ogston, A.G. (1963) The interaction between polysaccharides and other macromolecules and the osmotic pressure of mixtures of serum, albumin and hyaluronic acid. Biochem. J. 89: 249–253.CrossRefGoogle Scholar
  45. 45.
    Ogston, A.G. & Phelps, C.F. (1960) The partition of solutes between buffer solutions and solutions containing hyaluronic acid. Biochem. J. 78: 827–833.CrossRefGoogle Scholar
  46. 46.
    Preston, B.N., Laurent, T.C., Comper, W.D. & Checkley, G.J. (1980) Rapid polymer transport in concentrated solutions through the formation of ordered structures. Nature 287: 499–503.CrossRefGoogle Scholar
  47. 47.
    Toole, B.P. & Gross, J. (1971) The extracellular matrix of the regenerating newt limb: Synthesis and removal of hyaluronate prior to differentiation. Dev. Biol. 25: 57–77.CrossRefGoogle Scholar
  48. 48.
    Abatangelo, G., Martelli, M. & Vecchia, P. (1983) Healing of hyaluronic acid-enriched wounds: Histological observations. J. Surg. Res. 35: 410–416.CrossRefGoogle Scholar
  49. 49.
    Toole, B.P., Biswas, C. & Gross, J. (1979) Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc. Natl. Acad. Sci. U.S.A. 76: 6299–6303.CrossRefGoogle Scholar
  50. 50.
    Hakansson, L. & Venge, P. (1987) The molecular basis of the hyaluronic acid-mediated stimulation of granulocyte function. J. Immun. 138: 4347–52.Google Scholar
  51. 51.
    Forrester, J.V. & Lackie, J.M. (1981) Effect of hyaluronic acid on neutrophil adhesion. J. Cell. Sci. 50: 329–344.Google Scholar
  52. 52.
    Wasteson, A., Westermark, B., Lindahl, U. & Ponten, J. Aggregation of feline lymphoma cells by hyaluronic acid. Int. J. Cancer 12: 169–178.Google Scholar
  53. 53.
    Goldberg, R.L. & Toole, B.P. (1987) Hyaluronate inhibition of cell proliferation. Arth. Rheum. 30: 769–778.CrossRefGoogle Scholar
  54. 54.
    Hakansson, L., Hallgren, R., Venge, P., Artursson, G. & Vedung, S. (1980) Hyaluronic acid stimulates neutrophil function in vitro and in vivo. A review of experimental results and a presentation of a preliminary clinical trial. Scand. J. Infect. Dis. (Suppl.) 24: 54–57.Google Scholar
  55. 55.
    Roden, L. (1980) Structure and metabolism of connective tissue proteoglycans. In The Biochemistry of Glycoproteins and Proteoglycans (ed. Lennarz, W.J.), pp. 267–371. Plenum, NewYork.CrossRefGoogle Scholar
  56. 56.
    Mian, N. (1986) Character of a high Mr plasma membrane bound protein and assessment of its role as a constituent of Hyaluronate synthetase complex. Biochem. J. 237: 343–357.CrossRefGoogle Scholar
  57. 57.
    Prehm, P. (1983) Synthesis of hyaluronate in differentiated teratocarcinoma cells. Mechanism of chain growth. Biochem. J. 21: 191–198.CrossRefGoogle Scholar
  58. 58.
    Brecht, M., Mayer, U., Schlosser, E. & Prehm, P. (1986) Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem. J. 239: 445–450.CrossRefGoogle Scholar
  59. 59.
    Cohn, R.H., Cassiman, J.J. & Bernfield, M.R. (1976) Relationship of transformation, cell density and growth control to the cellular distribution of newly synthesized GAG. J. Cell Biol. 71: 280–293.CrossRefGoogle Scholar
  60. 60.
    Tomida, M., Koyama, H. & Ono, R. (1975) Induction of hyaluronic acid synthetase activity in rat fibroblasts by media change of confluent cultures. J. Cell Physiol. 86: 121–130.CrossRefGoogle Scholar
  61. 61.
    Laurent, T.C., Fraser, J.R.E., Pertoft, H. & Smedsrod, B. (1986) Binding of hyaluronate and chondroitin sulphate to liver endothelial cells. Biochem. J. 234: 653–658.CrossRefGoogle Scholar
  62. 62.
    Gibian, H. (1968) Hyaluronidases. In The Amino Sugars (ed. Jeanloz, R. & Balazs. E.A. Vol. IIB, pp. 181–200. Academic, New York.Google Scholar
  63. 63.
    Aronson, N.N. Jr & Davidson, E.A. (1967) Lysosomal hyaluronidase from rat liver. 1. Preparation. J. Biol. Chem. 242: 437–440.Google Scholar
  64. 64.
    Fraser, J.R.E., Appelgren, L.E. & Laurent, T.C. (1983) Tissue uptake of circulating hyaluronic acid. A whole body radiographic study. Cell Tissue Res. 233: 285–293.CrossRefGoogle Scholar
  65. 65.
    Laurent, T.C., Lilja, K., Brunnberg, L. et al. (1987) Urinary excretion of hyaluronan in man. Scand. J. Chem. Invest. 47: 793–799.CrossRefGoogle Scholar
  66. 66.
    Richter, W. (1974) Non-immunogenicity of purified hyaluronic acid preparations tested by passive cutaneous anaphylaxis, Arch. Allergy 47: 211–17.CrossRefGoogle Scholar
  67. 67.
    Richter, A.W., Ryde, E.M. & Zetterstrom, E.O. (1979) Non-immunogenicity of a purified sodium hyaluronate preparation in man. Int. Arch. Allergy Appl. Immun. 59: 45–48.CrossRefGoogle Scholar
  68. 68.
    Underhill, C.B. (1982) Naturally-occurring antibodies which bind hyaluronate. Biochem. Biophys. Res. Commun. 108: 129–30.CrossRefGoogle Scholar
  69. 69.
    Fillet, H.M., McCarty, M. & Blake, M. (1986) Induction of antibodies to hyaluronic acid by immunization of rabbits with encapsulated streptococci. J. exp. Med. 164: 762–776.CrossRefGoogle Scholar
  70. 70.
    Hruby, K. (1961) Hyaluronsaure als Glaskorparersatz bei Metzhautablosung. Klin. Mbl. Augenheilk 138: 484–496.Google Scholar
  71. 71.
    Balazs, E.A. & Sweeney, D. (1966) The replacement of the vitreous body in the monkey by reconstituted vitreous and by hyaluronic acid. Mod. Probl. Ophthalmol. 4: 230.Google Scholar
  72. 72.
    Balazs, E.A., Freeman, M.I., Kloti, R. et al. (1972) Hyaluronic acid and replacement of vitreous and aqueous humor. Mod. Probl. Ophthalmol. 10: 3–21.Google Scholar
  73. 73.
    Rydell, N. & Balazs, E.A. (1971) Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation Clin. Orthop. 80: 25–32.CrossRefGoogle Scholar
  74. 74.
    Peyron, J.G. & Balazs, E.A. (1974) Preliminary clinical assessment of Nahyaluronate injection into human arthritic joints. Path. Biol. 22: 731–736.Google Scholar
  75. 75.
    Miller, D., O’Connor, P. & Williams, J. (1977) Use of Na-hyaluronate during intraocular lens implantation in rabbits. Ophthal. Surg. 8: 58–61.Google Scholar
  76. 76.
    Laurent, T.C. (1955) A comparative study of physico-chemical properties of hyaluronic acid prepared according to different methods and from different tissues. Arkiv. Kemi. 11: 487–496.Google Scholar
  77. 77.
    Swann, D.A. (1968) Studies on hyaluronic acid. II. The protein components of rooster comb hyaluronic acid. Biochim. Biophys. Acta 160: 96–105.CrossRefGoogle Scholar
  78. 78.
    Boas, N. (1949) Isolation of hyaluronic acid from the cock’s comb. J. Biol. Chem. 181: 573–575.Google Scholar
  79. 79.
    Jeanloz, R.W. & Forchielli, E. (1950) Studies on hyaluronic acid and related substances. 1. Preparation of hyaluronic acid and derivatives from human umbilical cord. J. Biol. Chem. 186: 495–511.Google Scholar
  80. 80.
    Sevag, M.G. (1934) Eine neue physikalische Enteiweibungsmethode zur darstellung biologisch wirksamer Substanzen. Biochem. Z. 273: 419–429.Google Scholar
  81. 81.
    Blix, G. & Snellman, O. (1945) On chondroitin sulphuric acid and hyaluronic acid. Ark. Kemi Mineral. Geol. 19A, No. 32: 1–19.Google Scholar
  82. 82.
    Scott, J.E. (1960) Aliphatic ammonium salts in the assay of acidic polysaccharides from tissues. Meth. Biochem. Anal. 8: 145–197.CrossRefGoogle Scholar
  83. 83.
    Berman, E.R. (1963) Distribution and localization of various molecular species of hyaluronic acid in the bovine vitreous body. Exp. Eye Res. 2: 1–11.CrossRefGoogle Scholar
  84. 84.
    Caygill, J.C. (1971) Evidence for the aggregation of hyaluronate protein fractionated by chromatographic onagarose. Biochim. Biophys. Acta 244: 421–426.CrossRefGoogle Scholar
  85. 85.
    Ogston, A.G. & Stanier, J.E. (1950) On the state of hyaluronic acid in synovial fluid. Biochem. J. 46: 364–376.CrossRefGoogle Scholar
  86. 86.
    Constable, I.J. & Swann, D.A. (1972) Evaluation of the biological vitreous substitutes. The inflammation response in normal and altered. Arch. Ophthalmol. 88: 544–548.CrossRefGoogle Scholar
  87. 87.
    Hadidian, Z. & Pirie, N.W. (1952) High-viscosity hyaluronic acid. Patent US 2583096.Google Scholar
  88. 88.
    Hadidian, Z. & Pirie, N.W. (1952) High-viscosity hyaluronic acid. Patent US 2585546.Google Scholar
  89. 90.
    Balazs E.A. (1979) Ultranure hyaluronic acid and its use. Patent US 4141973.Google Scholar
  90. 91.
    Green Cross Corp. (1981) Production of hyaluronic acids from connective tissues. Patent JP 58084801.Google Scholar
  91. 92.
    Takahashi, T., Komiyama, Y., Oogushi, T. et al. (1986) Isolation of hyaluronic acid from cockscomb for pharmaceutical and cosmetic uses. Patent JP 61171703.Google Scholar
  92. 93.
    Cullis-Hill, D. (1986) Hyaluronic acid. Patent WO 8606728.Google Scholar
  93. 94.
    Kubota, H. (1979) Pyrogens and fungi removing agents. Patent JP 54067024.Google Scholar
  94. 95.
    Seki, M., Ogawa, Z., Inoue, Y. et al. (1988) Purification of hyaluronic acid. Patent JP 63270701.Google Scholar
  95. 96.
    Kono, S., Nishimura, H, Ishii, H. et al. (1989) Alumina for purification of hyaluronic acid. Patent JP 01313503.Google Scholar
  96. 97.
    Kitagawa, H., Chiba, S., Saegusa, H. et al. (1990) Purification of hyaluronic acid. Patent JP 02103204.Google Scholar
  97. 98.
    Yashizawa, Y., Yamada, K. & Fukui, F. (1990) Ultrafiltration membrane in purification of high-molecular-weight hyaluronic acid. Patent JP 02047101100.Google Scholar
  98. 99.
    Bracke, J.W. & Thacker, K. (1984) Hyaluronic acid from bacterial culture. Patent WO 8403302.Google Scholar
  99. 100.
    Brown, K.K. & Cooper, H. (1985) Use of ultrapure hyaluronic acid to improve animal joint function. Patent EP 143393.Google Scholar
  100. 101.
    Brown, K.K., Ruiz, L.L.C. & Van de Rijn, I. (1985) Ultrapure hyaluronic acid. Patent EP 144019.Google Scholar
  101. 102.
    Nimrod, A., Greenman, B., Kanner, D. et al. (1986) High molecular weight sodium hyaluronate by fermentation. Patent WO 8604355.Google Scholar
  102. 103.
    Akasaka, H. (1986) Bacterial production of hyaluronic acid. Patent JP 61219394.Google Scholar
  103. 104.
    Kurato, Y., Shibata, S., Kawahara, S. et al. (1987) Hyaluronic acid production by Streptococcus. Patent JP 62051999.Google Scholar
  104. 105.
    Morita, Y., Ushiyama, M. & Fujii, M. (1986) Manufacture of hyaluronic acid by fermentation method. Patent JP 61063294.Google Scholar
  105. 106.
    Miyazaki, T., Ochi, H., Shintani, K. et al. (1987) Fermentative production of hyaluronic acid. Patent JP 62215397.Google Scholar
  106. 107.
    Miyazaki, T., Ochi, H., Shintani, K. et al. (1987) Microbial production of hyaluronic acid. Patent JP 62289198.Google Scholar
  107. 108.
    Morikawa, K., Hamai, A. & Horie, K. (1987) Manufacture of hyaluronic acid for ophthalmological use. Patent JP 62257901.Google Scholar
  108. 109.
    Murata, H., Himoni, M. & Ishii, S. (1988) Manufacture of pyrogen-free hyaluronic acid from Streptococcus culture. Patent JP 63012293.Google Scholar
  109. 110.
    Miyamori, T., Numazawa, R., Sakimae, A. et at. (1988) High molecularweight hyaluronic acid manufactured by micro-organisms cultured in the presence of saccharides containing hydro-oyaromatic substituents. Patent EP 266578.Google Scholar
  110. 111.
    Chiba, S., Kitagawa, H. & Myoshi, T. (1988) Fermentative manufacture of high-molecular weight hyaluronic acid. Patent JP 63129991.Google Scholar
  111. 112.
    Chiba, S., Kitagawa, H., Hashimoto, M. et al. (1988) Enhancement of hyaluronic acid manufacture with Streptococcus equi ATCC 9527. Patent JP 63141594.Google Scholar
  112. 113.
    Kono, S., Ishii, H. Kogure, M. (1988) Chitosan for removal of bacteria from hyaluronic acid fermentation mixtures. Patent JP 63276493.Google Scholar
  113. 114.
    Hosoya, H., Kimura, M. & Endo, H. (1989) Hyaluronic acid and its manufacture with hyaluronidase-deficient Streptococcus mutant. Patent JP 01067196.Google Scholar
  114. 115.
    D’Hinterland, L.D., Normier, G., Durand, J. et al. (1989) Manufacture of high molecular weight hyaluronic acid by Streptococcus pyogenes. Patent FR 2617849.Google Scholar
  115. 116.
    Miyamoto, T., Numazawa, R. & Sakimae, A. (1989) Fermentative manufacture of hyaluronic acid. Patent JP 01225491.Google Scholar
  116. 117.
    Swann, D.A., Sullivan, B.P, Jamieson, G. et al. (1990) Hyaluronic acid and its manufacture with Streptococcus zooepidemicus. Patent US 4897349.Google Scholar
  117. 118.
    Sato, I., Shindo, T. & Kurokawa, Y. (1990) Hyaluronic acid fermentation, and effects of nitrogen sources. Patent JP 02058502.Google Scholar
  118. 119.
    Hashimoto, M., Saegusa, H., Chiba, S. et al. (1990) Sodium hyaluronate manufacture with Streptococcus equi. Patent US 4946780.Google Scholar
  119. 120.
    Weigel, P.H. & Papaconstantinou, J. (1991) Cloning of DNA encoding hyaluronate synthase. Patent WO 9103559.Google Scholar
  120. 121.
    Brown, K.K., Greene, N.D., Trump, S.L. et al. (1987) Sterilizable highmolecular weight hyaluronic acid for injection. Patent EP 228698.Google Scholar
  121. 122.
    Della Valle, F. & Aurelio, R. (1985) Hyaluronic acid fractions having therapeutic activity. Patent BE 900810.Google Scholar
  122. 123.
    Hildesheim, J. (1987) Non-inflammatory heat-resistant low mol. wt. hyaluronic acid, a process for extracting it from crude sources, and compositions containing it. Patent EP 239335.Google Scholar
  123. 124.
    Shindo, T., Hatakeyama, M. & Fujii, M. (1989) Hyaluronic acid and salts with low viscosity and nonenzymic process for their preparation. Patent JP 01266102.Google Scholar
  124. 125.
    Sugitani, H., Sugitani, T., Nozawa, T. et al. (1990) Manufacture of hyaluronic acid alkali salts having low degree of polymerization with Streptococcus or Pasturella. Patent JP 02234193.Google Scholar
  125. 126.
    Akasaka, H. & Yamaguchi, T. (1991) Production of low-molecular weight hyaluronic acid by shear. Patent WO 9104279.Google Scholar
  126. 127.
    Kurokawa, Y., Shindo, T. & Fujii, M. (1989) Manufacture of powdered sodium hyaluronate. Patent JP 01313502.Google Scholar
  127. 128.
    Egawa, K., Mori, S. & Yoshizawa, M. (1990) Mucopolysaccharide prosthetic fibers for surgical and dental use. Patent JP 02014019.Google Scholar
  128. 129.
    Kurokawa, Y., Hiraki, J. & Fujii, M. (1990) Manufacture of powdered sodium hyaluronate. Patent JP 02142801.Google Scholar
  129. 130.
    Shinohara, M. (1990) Manufacture of hyaluronic acid beads. Patent JP 02167301.Google Scholar
  130. 131.
    Chichuibu, K. (1988) Methods of assaying high molecular weight hyaluronic acid and reagent kits for the assay. Patent EP 283779.Google Scholar
  131. 132.
    Brandt, R.K. & Hedloef, M.E. (1988) Specific binding inhibition assay for determining hyaluronic acid. Patent EP 271461.Google Scholar
  132. 133.
    Corning Glass Works (1989) Proteoglycans and anti-keratan sulfate antibody for immunoassay of hyaluronic acid in body fluids. Patent JP 01029767.Google Scholar
  133. 134.
    Ghosh, P. & Kongtawelert, P. (1990) Inhibition method and kit for the detection and quantification of hyaluronan (hyaluronic acid) using polycationic material-coated solid support. Patent WO 9007121.Google Scholar
  134. 135.
    Pape, L.G. (1982) Ophthalmological procedures. Patent US 4328803.Google Scholar
  135. 136.
    Chang, A.S., Boyd, J.E., Koch, H.O. et al. (1985) Chondroitin sulfate/ sodium hyaluronate compositions. Patent EP 136782.Google Scholar
  136. 137.
    Shimizu, H. Green Cross Corp. (1985) Eye lotions containing hyaluronates. Patent JP 60084225.Google Scholar
  137. 138.
    Benanti, G. (1988) Anti-inflammatory formulations containing lysine salt of 4-diphenylacetic acid. Patent EP 261565.Google Scholar
  138. 139.
    Iwao, J., Iso, T., Uemura, O. et al. (1989) Manufacture of eye lotions containing sodium hyaluronate. Patent WO 8900044.Google Scholar
  139. 140.
    Nakada, K., Ogasawara, M. & Ichikawa, M. (1989) Manufacture of intraocular lens. Patent JP 01032859.Google Scholar
  140. 141.
    Iwata, S., Miyauchi, S. & Sakamoto, T. (1989) Hyaluronic acid (salts) for treatment of disorders in corneal epithelium. Patent JP 01238530.Google Scholar
  141. 142.
    Kita, K. (1989) Therapeutic film containing hyaluronic acid and fibronectin for treatment of corneal damage. Patent JP 01279836.Google Scholar
  142. 143.
    DeVore, D.P., Swann, D.A. & Sullivan, B.P. (1990) Sodium hyaluronate composition for eye surgery. Patent US 4920104.Google Scholar
  143. 144.
    Morita, T., Iso, T. & Kawashima, Y. (1990) Ophthalmic solutions containing hyaluronic acid (salts), benzalkonium chloride, and chelating agents. Patent JP 02164829.Google Scholar
  144. 145.
    Drenk, F. (1990) Topical compositions comprising fibroblast growth factor and hyaluronic acid for wound-healing promotion. Patent DE 3900198.Google Scholar
  145. 146.
    Takacsi Nagy, G., Takacsi, N.G., Tethey, I. et al. (1990) Hyaluronic acid metal complexes for epithelization acceleration. Patent WO 9010020.Google Scholar
  146. 147.
    Pierschbacher, M.D., Polarek, J.W., Petrica, M.P. et al. (1990) Polypeptidepolymer conjugates for wound healing. Patent WO 9006767.Google Scholar
  147. 148.
    De Belder, A.N. & Maelson, T. (1986) Gel for preventing adhesion between body tissues. Patent WO 8600912.Google Scholar
  148. 149.
    Goldberg, E.P. & Yaacobi, Y. (1989) Hydrophilic polymers for preventing tissue adhesions during surgery. Patent WO 8911857.Google Scholar
  149. 150.
    Lindblad, G. & Buckley, P. (1990) Dextran-hyaluronic acid mixture for prevention of adhesions between body tissues. Patent WO 9010031.Google Scholar
  150. 151.
    Green Cross Corp. (1983) Surgical dressings containing hyaluronic acid. Patent JP 58057319.Google Scholar
  151. 152.
    Shinohara, M., Kanda, T. & Igrashi, H. (1986) Bandages containing hyaluronic acid and amino acids and their derivatives. Patent JP 61187866.Google Scholar
  152. 153.
    Ishimura, F., Miyata, K., Katayose, H. et al. (1988) Films containing hyaluronic acid for manufacturing bandages. Patent JP 63159452.Google Scholar
  153. 154.
    Sugitani, H., Sugitani, T., Nozawa, T. et al. (1990) Manufacture of bandage from hyaluronic acid salts for wound healing. Patent JP 02268765.Google Scholar
  154. 155.
    Silver, F.H., Berg, R.A., Birk, D.E. et al. (1985) Biodegradable matrix. Patent WO 8504413.Google Scholar
  155. 156.
    Wallace, D.G., Reihanian, H., Pharriss, B.B. et al. (1988) Injectable implant composition containing a particulate biomaterial especially crosslinked collagen, and a lubricant which has improved intrudability and injectability. Patent EP 251695.Google Scholar
  156. 157.
    Silver, F.H., Berg, R.A., Doillon, C.J. et al. (1989) Biodegradable collagen compositions for treatment of skin wounds. Patent EP 314109.Google Scholar
  157. 158.
    Tsunenaga, M., Tominaga, N., Nishiyama, T. et al. (1989) Hyaluronic acidcontaining aqueous solution of aqueous dispersion of collagen for tissue substitution or repair. Patent EP 338813.Google Scholar
  158. 159.
    Sakurai, K. & Takuyasu, K. (1989) Manufacture of skin substttute with alcohol) and hyaluronic acid. Patent JP 01274767.Google Scholar
  159. 160.
    Shimada, M. Takigami, S., Uchida, T. et al. (1988) Manufacture of skin protectors from protein membranes on which hyaluronic acid is immobilized. Patent JP 63300770.Google Scholar
  160. 161.
    Breeze, J.H. (1989) Biodegradable, osteogenic, bone graft substitute. Patent GB 2215209.Google Scholar
  161. 162.
    Sakurai, K., Miyazaki, M., Tokuyasu, K. et al. (1989) Manufacture of basic materials for artificial cartilage. Patent JP 01268559.Google Scholar
  162. 163.
    Schultz, R.H., Wollen, T.H., Greene, N.D. et al. (1987) Hyaluronates for the treatment of pain associated with trauma. Patent EP 243867.Google Scholar
  163. 164.
    Yoneda, T. (1988) Aqueous lubricant compositions for gynaecological vaginal examinations. Patent JP 63218617.Google Scholar
  164. 165.
    Hills, B.A. (1989) Lubricants for joints and body tissue containing hyaluronates and phospholipids. Patent WO 8901777.Google Scholar
  165. 166.
    Balazs, E.A. & Leshchiner, A. (1985) Water-insoluble hyaluronic acid preparation. Patent DE 3434082.Google Scholar
  166. 167.
    Balazs, E.A. & Leshchiner, A. (1985) Water-insoluble hyaluronic acid. Patent FR 2556728.Google Scholar
  167. 168.
    Sakurai, K., Ueno, Y. & Okuyama, T. (1985) Crosslinked hyaluronic acid and its use. Patent EP 161887.Google Scholar
  168. 169.
    Maelson, T. & Lindqvist, B.L. (1986) Gel of crosslinked hyaluronic acid for use as a vitreous humor substitute. Patent WO 8600079.Google Scholar
  169. 170.
    Balazs, E.A. & Leshchiner, A. (1986) Crosslinked gels of hyaluronic acid and products containing these gels for cosmetics and pharmaceuticals. Patent US 4582865.Google Scholar
  170. 171.
    Balazs, E.A., Leshchiner, A. et al. (1989) Method for preparing hylan and novel hylan product. Patent EP 320164.Google Scholar
  171. 172.
    Balazs, E.A., Wedlock, D.J. & Phillips, G.O. (1984) Polymeric articles modified with hyaluronate. Patent US 4487865.Google Scholar
  172. 173.
    Balazs, E.A. & Leshchiner, A. (1985) Hyaluronate-coated polymeric articles. Patent US 4500676.Google Scholar
  173. 174.
    Halpern, G., Campbell, C., Beavers, E.M. et al. (1985) Hydrophilic coatings for plastics. Patent DE 3529758.Google Scholar
  174. 175.
    Sakurai, K. & Ueno, Y. (1986) Crosslinked glycosaminoglycan composites as artificial organs. Patent JP 61154567.Google Scholar
  175. 176.
    Kodama, A., Sakai, T., Tsuda, K. et al. (1986) Antithrombotic materials from polymers coated with mucopolysaccharides, collagens and crosslinking aldehyde compounds. Patent JP 61191364.Google Scholar
  176. 177.
    Maelson, T., Ahrgren, L. & De Belder, A.N. (1986) Shaped article. Patent EP 193510.Google Scholar
  177. 178.
    Maelson, T. (1987) Process for the manufacture of crosslinked carboxy group-containing polysaccharides. Patent SE 452469.Google Scholar
  178. 179.
    Della Valle, F. & Romeo, A. (1988) Crosslinked esters of hyaluronic acid, their preparation, and their pharmaceutical, cosmetic, medical and surgical uses. Patent EP 265116.Google Scholar
  179. 180.
    Halpern, G. & Gould, J.U. (1988) Prosthetic plastic article containing a top coat comprising an albumin and polysaccharide mixture. Patent US 4722867.Google Scholar
  180. 181.
    Leshchiner, A., Larsen, N.E., Balazs, E.A. et al. (1988) Cross-linked hyaluronate gels for percutaneous embolization. Patent EO 291177.Google Scholar
  181. 182.
    Aktiebolaget, L. (1956) Preparations with protracted corticotropic (ACTH) effect. Patent UK 761061.Google Scholar
  182. 183.
    Della Valle, F., Romeo, A. & Lorenzi, S. (1986) Hyaluronic acid containing medicaments for topical use. Patent EP 197718.Google Scholar
  183. 184.
    Balazs, E.A., Larsen, N.E. & Leshchiner, A. (1987) Drug delivery systems based on hyaluronan, derivatives thereof and their salts and method of producing same. Patent EP 224987.Google Scholar
  184. 185.
    Della Valle, F. & Romeo, A. (1987) Hyaluronic acid esters and their medical and cosmetic uses and formulations. Patent EP 216453.Google Scholar
  185. 186.
    Keller, N., Oleink, O. & Abelson, M.B. (1987) Sustained release compositions containing polysaccharides especially hyaluronic acid for injection into the eye. Patent EP 244178.Google Scholar
  186. 187.
    Cullis-Hill, D. & Ghosh, P. (1988) Polysaccharide sulfate metal complexes for anti-inflammatory compositions. Patent WO 8807060. 188. Ellwood, D.C. (1988) Hyaluronic acid derivatives as sustained-release pharmaceuticals. Patent EP 296740.Google Scholar
  187. 189.
    Hamilton, R.G., Fox, E.M., Acharya, R.A. et al. (1989) Water-insoluble biocompatible derivatives of hyaluronic acid, their manufacture and use. Patent WO 8902445.Google Scholar
  188. 190.
    Mohler, M.A. & Nguyen Tue, H. (1989) Topical pharmaceuticals containing sparingly water-soluble enzymes for the prevention of fibrin deposition or adhesion formation in wounds. Patent EP 297860.Google Scholar
  189. 191.
    Machida, M. & Arakawa, M. (1989) Manufacture of slow-release pharmaceutical microgranules. Patent JP 01156912.Google Scholar
  190. 192.
    Myazaki, T., Terasawa, K., Inoe, K. et al. (1989) Sustained-release subcutaneous or intramuscular preparations containing hyaluronic acid (salts). Patent JP 01287041.Google Scholar
  191. 193.
    Kawamori, R., Nomura, M., Kubota, S. et al. (1989) Sustained release insulin ophthalmic solutions. Patent JP 01294633.Google Scholar
  192. 194.
    Dalla Valle, F. & Romeo, A. (1989) Preparation of crosslinked carboxy polysaccharides as biodegradable plastic materials for cosmetics and pharmaceuticals. Patent EP 341745.Google Scholar
  193. 195.
    Hoshi, K., Yanagawa, A., Mizushima, Y. et al. (1989) Superoxide dismutasecontaining topical drug preparations. Patent JP 01319427.Google Scholar
  194. 196.
    Kitano, S. & Kitazato, K. (1990) Sustained-release preparations for physiologically active peptides. Patent JP 02000213.Google Scholar
  195. 197.
    Koide, M. & Konishi, A. (1990) Biocompatible materials for preparation of prosthetics and microcapsules. Patent JP 02001287.Google Scholar
  196. 198.
    Maelson, T. & Lindqvist, B. (1990) Phosphorus-crosslinked hyaluronate gels, their use and method for producing them. Patent WO 9009401.Google Scholar
  197. 199.
    Nimrod, A. & Greenman, B. (1987) Heavy metal salts of hyaluronic acid useful as antimicrobial agents. Patent WO 8705517.Google Scholar
  198. 200.
    Maddren, L.T. (1990) Topical treatment of herpesvirus hominis. Patent WO 9014095.Google Scholar
  199. 201.
    Miyoshi, T. & Kitagawa, H. (1990) Sustained-release nasal sprays containing hyaluronic acid. Patent JP 02032013.Google Scholar
  200. 202.
    Nakamura, M. & Shudo, K. (1990) Nasal drops containing sorbitol, pyrrolidonecarboxylic acid, and hyaluronic acid for treatment of snoring. Patent JP 20253728.Google Scholar
  201. 203.
    Saito, S. (1981) Synergistic composition for stimulating phagocytic activity, comprising a solution containing muramidase and a hyaluronic acid salt. Patent FR 2466990.Google Scholar
  202. 204.
    Wenge, P.S.W., Haakansson, L.D. & Haellgren, H. (1988) Method of enhancing the host defense with hyaluronic acid. Patent US 4725585.Google Scholar
  203. 205.
    Uhlin, A.G. (1980) Immunization agent, and use thereof for producing antisera. Patent EP 14995.Google Scholar
  204. 206.
    Ueno, H., Motoyuki, C. & Okanari, E. (1990) Hyaluronic acid-modified superoxide dismutase with improved in vivo half-life. Patent JP 02231078.Google Scholar
  205. 207.
    Sakurai, K. & Miyazaki, T. (1990) Modification of non-human superoxide dismutase with glycosaminoglycans. Patent JP 02273176.Google Scholar
  206. 208.
    Sakurai, K., Horie, K. & Sakamoto, T. (1986) Mucopolysaccharides as neoplasm inhibitors. Patent JP 61000017.Google Scholar
  207. 209.
    Bergman, P., Steen, Y. & Ingelman, B.G.A. (1987) Process for separating motile sperm cells in vitro, fertilization method and penetration medium containing hyaluronate for sperm cells. Patent WO 8702382.Google Scholar
  208. 210.
    Skinsnes, O.K. & Matsuo, E. (1976) Mycobacteria culture medium and method for in vitro cultivation of leprosy mycobacteria. Patent US 3983003.Google Scholar
  209. 211.
    Horie, K., Matsubara, T. & Tokuyasu, K. (1989) Hyaluronates as inhibitors of epidermal cell growth in blood vessels. Patent JP 01290631.Google Scholar
  210. 212.
    Lindblad, G.T.O. (1986) Hyaluronic acid preparation for treating inflammation of skeletal joints. Patent WO 8605984.Google Scholar
  211. 213.
    Yamagami, Y., Oguro, Y. & Muto, T. (1986) Tonic pharmaceuticals containing chondroitin sulfuric acid and hyaluronic acid. Patent JP 61047418.Google Scholar
  212. 214.
    Hiramori, T. & Nishimura, M. (1987) Beverages containing hyaluronic acid, its derivatives, and salts obtained from the Dead Sea. Patent JP 62224268.Google Scholar
  213. 215.
    Pola Chemical Industries, Inc. (1984) Hair conditioners containing hyaluronic acid. Patent JP 59110612.Google Scholar
  214. 216.
    Tanaka, N. Yoshida, S. (1986) Hair tonics containing hyaluronic acid-protein complexes and placental extract. Patent JP 61043104.Google Scholar
  215. 217.
    Furuya, T. (1987) Hair wave-setting preparations containing mucopolysaccharides. Patent JP 62042914.Google Scholar
  216. 218.
    Solomon, H., Catsimpoolas, N., Klein, J. et al. (1988) Treatment of alopecia by compositions containing omental lipids and sodium hyaluronate. Patent WO 8804931.Google Scholar
  217. 219.
    Scott, I.R. (1988) Skin treatment composition and hair growth stimulant comprising hyaluronic acid fragments. Patent EP 295092.Google Scholar
  218. 220.
    Yagi, H. (1990) Electrically conductive compositions. Patent JP 02014229.Google Scholar
  219. 221.
    Saito, M. (1987) Water-thinned ink composition. Patent JP 62004764.Google Scholar
  220. 222.
    Arisawa, K., Takagishi, I. & Kawabata, K. (1988) Drying-resistant waterbased ink compositions for writing apparatus. Patent JP 63210181.Google Scholar
  221. 223.
    Oka, T. (1989) Anticlogging water-thinned writing ink compositions. Patent JP 01174575.Google Scholar
  222. 224.
    Arai, N., Nojima, M. & Kanda, N. (1990) Thermal printing material having hyaluronic acid. Patent JP 02025378.Google Scholar
  223. 225.
    Brown, T.J., Laurent, U.B. & Fraser, J.R. (1991) Turnover of hyaluronan in synovial fluids: elimination of labelled hyaluronan from the knee joint of the rabbit.Google Scholar
  224. 226.
    Bertolami, C.N., Gay, T., Swann, D.A. et al. (Manuscript in preparation.)Google Scholar
  225. 227.
    Kuo, J.-W., Swann, D.A. & Prestwich, G.D. (1991) Chemical modification of hyaluronic acid by carbodiimides. Bioconjugate Chem. 2: 232–241.CrossRefGoogle Scholar

Copyright information

© Palgrave Macmillan, a division of Macmillan Publishers Limited and ICI Biological Products Business 1991

Authors and Affiliations

  • David A. Swann
    • 1
  • Jing-wen Kuo
    • 1
  1. 1.Medchem Products Inc.WoburnUSA

Personalised recommendations